MDSAP certification is an essential milestone towards commercialisation of the Lenire tinnitus treatment device in Australia and Canada. Following MDSAP certification, Neuromod Devices have secured regulatory approval for Lenire from both Australia’s Therapeutic Goods Administration […]
MDSAP certification is an essential milestone towards commercialisation of the Lenire tinnitus treatment device in Australia and Canada. Following MDSAP certification, Neuromod Devices have secured regulatory approval for Lenire from both Australia’s Therapeutic Goods Administration […]
GUANG’AN, China, Sept. 22, 2025 /PRNewswire/ — PHASE Scientific International Limited (“PHASE Scientific”) today announced the official launch of the world’s largest clinical study for urine-based cervical cancer (HPV) screening, with the first site established in […]
CENTER VALLEY, Pa., Sept. 19, 2025 /PRNewswire/ — Olympus Corporation has announced a voluntary, global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) manufactured prior to May 12, 2025, […]
CENTER VALLEY, Pa., Sept. 19, 2025 /PRNewswire/ — Olympus Corporation has announced a voluntary, global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) manufactured prior to May 12, 2025, […]
